Apellis Pharmaceuticals Correlations

APLS Stock

USD 23.49 0.93 4.12%

The current 90-days correlation between Apellis Pharmaceuticals and Catalyst Pharmaceuticals is 0.24 (i.e., Modest diversification). The correlation of Apellis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Apellis Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Apellis Pharmaceuticals and DJI is 0.52 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Apellis Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apellis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.

Moving together with Apellis Stock

0.66	IMMP	Immutep Ltd ADR	Pair Corr
0.62	AVE	Avecho Biotechnology	Pair Corr
0.63	SVRA	Savara Inc	Pair Corr

Moving against Apellis Stock

0.73	IMRN	Immuron Ltd ADR	Pair Corr
0.45	EVGN	Evogene	Pair Corr
0.44	QSI	QuantumSi	Pair Corr
0.41	EDIT	Editas Medicine	Pair Corr
0.39	GNLX	Genelux Common	Pair Corr
0.36	JUMP	Leveljump Healthcare Corp	Pair Corr
0.34	KRRO	Frequency Therapeutics	Pair Corr
0.47	RNAZ	Transcode Therapeutics Upward Rally	Pair Corr
0.44	ACXP	Acurx Pharmaceuticals LLC	Pair Corr
0.32	MBIO	Mustang Bio	Pair Corr

Related Correlations Analysis

	CPRX	KNSA	MLYS	BEAM	CDTX	ADPT	SRRK	IDYA	AGIO	RXRX
CPRX		0.71	-0.48	0.35	0.52	0.34	0.72	0.26	-0.53	-0.48	CPRX
KNSA	0.71		-0.33	0.16	0.42	0.25	0.55	0.24	-0.42	-0.4	KNSA
MLYS	-0.48	-0.33		-0.72	-0.76	-0.34	-0.62	-0.25	0.54	0.09	MLYS
BEAM	0.35	0.16	-0.72		0.7	0.41	0.67	0.65	-0.56	0.34	BEAM
CDTX	0.52	0.42	-0.76	0.7		0.28	0.52	0.4	-0.44	-0.14	CDTX
ADPT	0.34	0.25	-0.34	0.41	0.28		0.33	0.28	-0.46	0.1	ADPT
SRRK	0.72	0.55	-0.62	0.67	0.52	0.33		0.66	-0.79	-0.19	SRRK
IDYA	0.26	0.24	-0.25	0.65	0.4	0.28	0.66		-0.58	0.25	IDYA
AGIO	-0.53	-0.42	0.54	-0.56	-0.44	-0.46	-0.79	-0.58		0.08	AGIO
RXRX	-0.48	-0.4	0.09	0.34	-0.14	0.1	-0.19	0.25	0.08		RXRX
	CPRX	KNSA	MLYS	BEAM	CDTX	ADPT	SRRK	IDYA	AGIO	RXRX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SRRK	+ 0.72	CPRX
KNSA	+ 0.71	CPRX
CDTX	+ 0.7	BEAM
SRRK	+ 0.67	BEAM
IDYA	+ 0.66	SRRK
IDYA	+ 0.65	BEAM

High negative correlations

AGIO	- 0.79	SRRK
CDTX	- 0.76	MLYS
BEAM	- 0.72	MLYS
SRRK	- 0.62	MLYS
AGIO	- 0.58	IDYA
AGIO	- 0.56	BEAM

Risk-Adjusted Indicators

There is a big difference between Apellis Stock performing well and Apellis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Apellis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CPRX	1.49	0.00	0.06	0.00	1.73	(1.57)	3.00	(3.20)	11.73
KNSA	1.67	0.18	0.06	0.49	2.00	(1.80)	3.33	(3.63)	10.07
MLYS	2.64	(0.41)	0.00	(0.18)	0.00	0.00	6.62	(6.42)	24.91
BEAM	3.38	0.21	0.08	0.20	3.50	(4.10)	8.12	(6.30)	31.78
CDTX	4.25	1.68	0.64	1.82	1.30	(4.61)	5.93	(4.54)	105.72
ADPT	3.19	(0.04)	0.00	(0.56)	0.00	0.00	9.94	(6.49)	29.55
SRRK	3.03	0.80	0.27	0.89	2.48	(3.66)	7.07	(4.70)	31.68
IDYA	1.96	0.05	0.01	0.15	2.20	(2.14)	4.86	(3.78)	10.56
AGIO	3.06	(0.41)	0.00	(0.17)	0.00	0.00	5.99	(3.94)	56.88
RXRX	3.41	(0.49)	0.00	(0.10)	0.00	0.00	7.87	(5.83)	20.15

Apellis Pharmaceuticals Corporate Management

James CPA	Corporate VP	Profile
Cedric MD	President, CoFounder	Profile
Adam Townsend	Chief Commercial Officer	Profile
Philip MD	Chief Advisor	Profile
Karen Lewis	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC